↓ Skip to main content

Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore

Overview of attention for article published in BMC Cancer, May 2011
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore
Published in
BMC Cancer, May 2011
DOI 10.1186/1471-2407-11-178
Pubmed ID
Authors

Gilberto de Lima Lopes

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Singapore 1 2%
Canada 1 2%
Unknown 40 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 21%
Student > Bachelor 6 14%
Student > Postgraduate 5 12%
Researcher 5 12%
Student > Ph. D. Student 4 10%
Other 6 14%
Unknown 7 17%
Readers by discipline Count As %
Medicine and Dentistry 16 38%
Pharmacology, Toxicology and Pharmaceutical Science 5 12%
Economics, Econometrics and Finance 2 5%
Business, Management and Accounting 2 5%
Agricultural and Biological Sciences 2 5%
Other 6 14%
Unknown 9 21%